Breast-cancer drug wins FDA approval

Article Abstract:

A new breast cancer drug, Tykerb from GlaxoSmithKline PLC of the United Kingdom has been approved by the United States Food and Drug Administration for sale in the United States. The drug is especially for advanced breast cancer and for cases that have not responded to other drugs.

Drug therapy, Breast cancer, Drug overview, Financial report, Tykerb (Medication)

---

Glaxo seeks approval for drug

Article Abstract:

GlaxoSmithKline PLC of the United Kingdom is seeking United States Food and Drug Administration approval for a weaker version of the medication Xenical. The approval of the over-the-counter weight loss medication would be the first of its kind in the United States.

United Kingdom, Weight reducing preparations, Anti-obesity agents

---

Merck cervical-cancer vaccine cleared for use in girls, women

Article Abstract:

Gardasil, a vaccine developed by Merck and Company Inc. of the United States to protect women from cervical cancer has been approved by the United States Food and Drug Administration. The vaccine protects against four strains of human papillomavirus.

Merck & Company Inc., Gardasil (Vaccine)

Similar abstracts:

• Abstracts: Telstra's privatization plan encounters mounting obstacles. Telstra stock sale could be in jeopardy amid war of words
• Abstracts: High-tech researcher is 'super-silent'. New policies to sustain stocks. Australian prawn stocks rebuilding
• Abstracts: U.K.'s Boots to refocus on drugs with Alliance UniChem merger. Deutsche Boerse under attack over LSE bid
• Abstracts: Implementation of yield management practices in service organizations: empirical findings from a major hotel group
• Abstracts: ABN posts higher net, shifts strategy for Italian bank stake

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.